alexa
Reach Us 44-1753390542
Editor - Masao Kakoki | The University of North Carolina | 20113

Cardiovascular Therapy: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Masao Kakoki

Masao Kakoki
Masao Kakoki
Associate Professor 
Pathology and Laboratory Medicine
The University of North Carolina
USA
The University of North Carolina

Biography

Dr. Masao Kakoki is a physician-scientist in nephrology and cardiovascular medicine. He obtained the M.D. and Ph.D. degrees at the University of Tokyo in Japan. Since he joined Dr. Oliver Smithies’ laboratory in 2001, he has devoted himself to molecular biology with emphasis on understanding the molecular mechanisms that are responsible for cardiovascular and renal dysfunction in diabetes mellitus and aging using genetically altered mice. He proposed in 2004 a unique mouse model to modify the expression of the gene of interest in a wide range, which was cited as “three prime mice”. This technique alter gene expression in mice by targeted replacement of the 3’ untranslated region (UTR) of the gene of interest with more unstable 3’UTR or with more stable 3’UTR. He is studying the renal and cardiovascular phenotype in mice with graded expression levels of therapeutic candidate genes to find new ways to prevent or treat diabetes- and aging-associated complications in humans.

Research Interest

He is studying the renal and cardiovascular phenotype in mice with graded expression levels of therapeutic candidate genes to find new ways to prevent or treat diabetes- and aging-associated complications in humans.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

An Example of Controversies on Anti-fibrosis Therapies in Cardiovascular Diseases: Transforming Growth Factor β1

Masao Kakoki
Editorial: Cardiovasc Ther 2016, 1: e101
Top